<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>FenNILPharm</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            line-height: 1.6;
            color: #333;
            background: #fafafa;
        }

        nav {
            position: sticky;
            top: 0;
            background: white;
            box-shadow: 0 1px 3px rgba(0,0,0,0.1);
            z-index: 100;
        }

        nav ul {
            display: flex;
            justify-content: center;
            gap: 2rem;
            list-style: none;
            padding: 1rem;
            flex-wrap: wrap;
        }

        nav a {
            text-decoration: none;
            color: #333;
            font-weight: 500;
            transition: color 0.3s;
        }

        nav a:hover {
            color: #0066cc;
        }

        section {
            max-width: 900px;
            margin: 0 auto;
            padding: 4rem 2rem;
            scroll-margin-top: 60px;
        }

        h1 {
            font-size: 2.5rem;
            margin-bottom: 0.5rem;
            color: #1a1a1a;
        }

        h2 {
            font-size: 1.8rem;
            margin-top: 2rem;
            margin-bottom: 1rem;
            color: #1a1a1a;
            border-bottom: 2px solid #0066cc;
            padding-bottom: 0.5rem;
        }

        p {
            margin-bottom: 1rem;
            text-align: justify;
        }

        .subtitle {
            font-size: 1.1rem;
            color: #666;
            margin-bottom: 2rem;
        }

        .publication {
            background: white;
            padding: 1rem;
            margin: 1rem 0;
            border-left: 4px solid #0066cc;
            border-radius: 4px;
        }

        .team-member {
            display: inline-block;
            background: white;
            padding: 1rem;
            margin: 0.5rem;
            border-radius: 4px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.1);
            min-width: 200px;
        }

        footer {
            text-align: center;
            padding: 2rem;
            color: #666;
            font-size: 0.9rem;
            border-top: 1px solid #ddd;
            margin-top: 4rem;
        }
    </style>
</head>
<body>
    <nav>
        <ul>
            <li><a href="#scope">Scope</a></li>
            <li><a href="#results">Results</a></li>
            <li><a href="#publications">Publications</a></li>
            <li><a href="#team">Team</a></li>
            <li></li>
            <li><a href="index_ro.html">Ro</a></li>
        </ul>
    </nav>

    <section id="home">
        <h1>Fenton-type nanocatalysts with applications in wastewater treatment (FenNILPharm)</h1>
        <p class="subtitle">A brief description of your research project goes here.</p>
    </section>

    <section id="scope">
        <h2>Objectives for 2025</h2>
        <p>Development of synthesis methods for new 1H-imidazole derivatives and investigation of the possibilities of chemical transformations of these compounds into products containing Fe with practical importance. Synthesis of functionalized ionic liquids based on 1H-imidazole and investigation of their properties.</p>
        <p><strong>Objectives:</strong></p>
        <ul style="margin-left: 1.5rem; margin-bottom: 1rem;">
            <li>Scientific documentation through the study of specialized literature regarding new synthesis methods for target compounds.</li>
            <li>Development of synthesis and analysis methods for ionic liquids.</li>
            <li>Exchange of best practices and knowledge transfer.</li>
        </ul>
    </section>

    <section id="results">
        <h2>Results</h2>
        <p>For the first time, a complete cycle of creating new precursors for the preparation of novel 1H-imidazole derivatives was carried out, starting from design to synthesis and complete structural characterization by various methods of physicochemical analysis, including X-ray diffractometry. The proposed methods allowed the synthesis of series of imidazoles with important practical properties. For the first time, the influence of the length of the alkyl fragment of chloroalkyl nitriles on the yield of imidazolium salts has been studied. The property of the studied compounds to generate singlet oxygen as a photosensitizer was also investigated. The newly synthesized salts of substituted imidazole tetrachloroferrate were also evaluated for anticancer activity against various solid tumor and hematological cancer cell lines. Four compounds 18-21 showed activity exclusively against a single tumor cell line - LN229 (glioblastoma) in the concentration range of 1.0–4.0 µM, comparable to that of the reference compound etoposide.
        </p>
        <p>
            The research results were presented at the international conference "Medicine, Molecular and Environmental Sciences Congress (MedMolMed)" 2025, November 10-15, 2025, Chisinau, Republic of Moldova.
        </p>
    </section>

    <section id="publications">
        <h2>Publications</h2>
        <div class="publication">
            <strong>Molecular diversity of ionic liquids: preparation of novel scaffolds and focused targets.</strong><br>
            MACAEV F. Medicine, Molecular and Environmental Sciences Congress (MedMolMed) 2025, November 10-15, 2025, Chișinău, Republic of Moldova, p.13.  <a href="https://doi.org/10.19261/medmol25">https://doi.org/10.19261/medmol25</a>
        </div>
        <div class="publication">
            <strong>Anti-glioblastoma activity and singlet oxygen generation of novel imidazole-based tetrachloroferrates.</strong><br>
            NEAMȚU M., SUCMAN N., POGREBNOI V., CEABANOVA (ZVEAGHINȚEVA) M., MACAEV F. Medicine, Molecular and Environmental Sciences Congress (MedMolMed) 2025, November 10-15, 2025, Chișinău, Republic of Moldova, p.54. <a href="https://doi.org/10.19261/medmol25">https://doi.org/10.19261/medmol25</a>
        </div>
    </section>

    <section id="team">
        <h2>Team</h2>
        <div class="team-member"><strong>Dr.hab. Macaev Fliur</strong></div>
        <div class="team-member"><strong>Dr. Sucman Natalia</strong></div>
        <div class="team-member"><strong>Dr. Pogrebnoi Vsevolod</strong></div>
        <div class="team-member"><strong>Dr. Ceabanova (Zveaghințeva) Marina</strong></div>
    </section>

    <footer>
        <p>&copy; 2025 All rights reserved.</p>
    </footer>
</body>
</html>